+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-18Number of Pages: 162

Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Global Hepatitis E Diagnostic Tests Market: Snapshot

The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene, making it imperative for the diagnosis of hepatitis E. These factors have spurred the demand for hepatitis E diagnostic tests, especially among young adults in the age of 15 to 40 years. The growing awareness of the related symptoms of the disease has propelled the growth of the market in various regions.

The global hepatitis E diagnostic tests market is anticipated to rise at a CAGR of 3.80% from 2016 to 2024. The market was valued at US$43.7 mn in 2015 and expected to reach US$60.4 mn by the end of the forecast period.

The global hepatitis E diagnostic tests market is extremely competitive with the leading players adopting a competitive pricing strategy of various diagnostic tests, including the kits used for the primary ELISA HEV IgM tests. 

hepatitis e diagnostic tests market

 

Hepatitis E Hyper-endemicity in Asian Economies to Ensure Dominance of Asia Pacific Region

On the basis of geography, the global market is segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. Of these, Asia Pacific is the leading regional market. The impressive growth of the market is attributed to hepatitis E assuming endemic proportions in various Asian countries, especially resource-poor regions, such as Nepal, Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand, and Bhutan. The regional market is poised to attain a share of over 48% by the end of 2024.

Besides, the Middle East and Africa is expected to witness a steady and substantial demand for the hepatitis E diagnostic tests. The growth in the regional market is driven by increasing prevalence of hepatitis E in countries such as Kenya, Uganda, Nigeria, and Morocco attributable to poor hygienic conditions, limited access to safe drinking water, and lack of sanitation. The soaring number of people suffering from Hepatitis E, especially the prevalence of the disease across pregnant women, has made it a public health concern in the region. Consequently, the governments of various countries of Africa are making evidence-based control policies, including the modes of transmission. Timely treatment calls for extensive tests for people who are more prone to infections, especially those using contaminated piped water.  This has spurred the demand for Hepatitis E diagnostic tests fuelling the regional market.

North America and Europe markets are expected to witness only incremental growth over the forecast period.

RT-PCR diagnostic Test Gaining Wide Adoption

Among the different types of diagnostic tests for hepatitis E, the primary tests are ELISA HEV IgM test kits, ELISA HEV IgG test kits, and RT-PCR test kits. The market has witnessed an extensive demand for ELISA HEV IgM test kits. Owing to growing seroprevalence of hepatitis E across the globe, market analysts expect the demand for ELISA HEV IgM diagnostic test kits to soar significantly over the forecast period. The demand for RT-PCR test kits is expected to closely follow that of ELISA HEV IgM test kits in the coming years. The use of RT-PCR diagnostic test among clinicians is propelled by the rapid generation of results and the high sensitivities and specificities of the molecular assay. On the other hand, the ELISA HEV IgG test kits segment is expected to register a modest growth along the forecast period.

Companies vying for a significant share in the global market for hepatitis E diagnostic tests include Beijing Wantai Biological Pharmacy, Primerdesign Ltd., Mikrogen GmBH, MP Biomedicals LLC, Fast-track diagnostics Ltd., Fortress Diagnostics Ltd., F. Hoffmann-La Roche Ltd., Biokit S.A., and Altana Diagnostics GmbH.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hepatitis E Diagnostic Tests Market

4. Market Overview
     4.1. Introduction
     4.2. Key Market Indicators
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
     4.4. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, 2014–2024
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis
     4.6. Value Chain Analysis
            4.6.1. List of active market participants
     4.7. Disease Overview
     4.8. Regulatory approval process
     4.9. Market Outlook

5. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Test Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            5.4.1. HEV IgM ELISA Test kits
            5.4.2. HEV IgG ELISA Test kits
            5.4.3. RT-PCR Test kits
            5.4.4. Others
     5.5. Test Type Comparison Matrix
     5.6. Market Attractiveness, by Test Type

6. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By End User
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value (US$ Mn) Forecast By End User, 2014–2024
            6.4.1. Hospitals
            6.4.2. Diagnostic Laboratories
            6.4.3. Research Centers
            6.4.4. Point of Care
     6.5. End User Comparison Matrix
     6.6. Market Attractiveness by End User

7. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Market Value (US$ Mn) Forecast By Region
            7.3.1. North America
            7.3.2. Europe
            7.3.3. Asia Pacific
            7.3.4. Latin America
            7.3.5. Middle East & Africa
     7.4. Market Attractiveness by Country/Region

8. North America Hepatitis E Diagnostic Tests Market Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
            8.1.2. Key Trends
     8.2. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            8.2.1. HEV IgM ELISA Test kits
            8.2.2. HEV IgG ELISA Test kits
            8.2.3. RT-PCR Test kits
            8.2.4. Others
     8.3. Market Value (US$ Mn) Forecast By End User, 2014–2024
            8.3.1. Hospitals
            8.3.2. Diagnostic Laboratories
            8.3.3. Research Centers
            8.4.4. Others
     8.4. Market Value (US$ Mn) Forecast By Country, 2014–2024
            8.4.1. US
            8.4.2. Canada
     8.5. Market Attractiveness Analysis
            8.5.1. By Test Type
            8.5.2. By End User
            8.5.3. By Country

9. Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast    
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            9.2.1. HEV IgM ELISA Test kits
            9.2.2. HEV IgG ELISA Test kits
            9.2.3. RT-PCR Test kits
            9.2.4. Others
     9.3. Market Value (US$ Mn) Forecast By End User, 2014–2024
            9.3.1. Hospitals
            9.3.2. Diagnostic Laboratories
            9.3.3. Research Centers
            9.3.4. Point of Care
     9.4. Market Value (US$ Mn) Forecast By Country, 2014–2024
            9.4.1. Brazil
            9.4.2. Mexico
            9.4.3. Rest of Latin America
     9.5. Market Attractiveness Analysis
            9.5.1. By Test Type
            9.5.2. By End User
            9.5.3. By Country

10. Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            10.2.1. HEV IgM ELISA Test kits
            10.2.2. HEV IgG ELISA Test kits
            10.2.3. RT-PCR Test kits
            10.2.4. Others
     10.3. Market Value (US$ Mn) Forecast By End User, 2014–2024
            10.3.1. Hospitals
            10.3.2. Diagnostic Laboratories
            10.3.3. Research Centers
            10.3.4. Point of Care
     10.4. Market Value (US$ Mn) Forecast By Country, 2014–2024
            10.4.1. UK
            10.4.2. Germany
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis
            10.5.1. By Test Type
            10.5.2. By End User
            10.5.3. By Country

11. Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            11.2.1. HEV IgM ELISA Test kits
            11.2.2. HEV IgG ELISA Test kits
            11.2.3. RT-PCR Test kits
            11.2.4. Others
     11.3. Market Value (US$ Mn) Forecast By End User, 2014–2024
            11.3.1. Hospitals
            11.3.2. Diagnostic Laboratories
            11.3.3. Research Centers
            11.3.4. Point of Care
     11.4. Market Value (US$ Mn) Forecast By Country, 2014–2024
            11.4.1. China
            11.4.2. Japan
            11.4.3. India
            11.4.4. Australia
            11.4.5. Rest of Asia Pacific
     11.5. Market Attractiveness Analysis
            11.5.1. By Test Type
            11.5.2. By End User
            11.5.3. By Country

12. Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value (US$ Mn) Forecast By Test Type, 2014–2024
            12.2.1. HEV IgM ELISA Test kits
            12.2.2. HEV IgG ELISA Test kits
            12.2.3. RT-PCR Test kits
            12.2.4. Others
     12.3. Market Value (US$ Mn) Forecast By End User, 2014–2024
            12.3.1. Hospitals
            12.3.2. Diagnostic Laboratories
            12.3.3. Research Centers
            12.3.4. Point of Care
     12.4. Market Value (US$ Mn) Forecast By Country, 2014–2024
            12.4.1. South Africa
            12.4.2. UAE
            12.4.3. Rest of Middle East & Africa
     12.5. Market Attractiveness Analysis
            12.5.1. By Test Type
            12.5.2. By End User
            12.5.3. By Country

13. Competition Landscape
     13.1. Market Player – Competition Matrix (By Tier and Size of companies)
     13.2. Market Share Analysis by Company (2015)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Altana Diagnostics GmbH
                      13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.1.2. Business Overview
                      13.3.1.3. Product Portfolio 
                      13.3.1.4. Financial Overview 
                      13.3.1.5. SWOT Analysis 
                      13.3.1.6. Strategic overview
            13.3.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
                      13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.2.2. Business Overview
                      13.3.2.3. Product Portfolio 
                      13.3.2.4. Financial Overview 
                      13.3.2.5. SWOT Analysis 
                      13.3.2.6. Strategic overview
            13.3.3. Biokit S.A.
                      13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.3.2. Business Overview
                      13.3.3.3. Product Portfolio 
                      13.3.3.4. Financial Overview 
                      13.3.3.5. SWOT Analysis 
                      13.3.3.6. Strategic overview
            13.3.4. Dia.Pro - Diagnostic Bioprobes s.r.l
                      13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.4.2. Business Overview
                      13.3.4.3. Product Portfolio 
                      13.3.4.4. Financial Overview 
                      13.3.4.5. SWOT Analysis 
                      13.3.4.6. Strategic overview
            13.3.5. F. Hoffmann-La Roche Ltd.
                      13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.5.2. Business Overview
                      13.3.5.3. Product Portfolio 
                      13.3.5.4. Financial Overview 
                      13.3.5.5. SWOT Analysis 
                      13.3.5.6. Strategic overview
            13.3.6. Fast-track diagnostics Ltd.
                      13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.6.2. Business Overview
                      13.3.6.3. Product Portfolio 
                      13.3.6.4. Financial Overview 
                      13.3.6.5. SWOT Analysis 
                      13.3.6.6. Strategic overview
            13.3.7. Fortress Diagnostics Limited
                      13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.7.2. Business Overview
                      13.3.7.3. Product Portfolio 
                      13.3.7.4. Financial Overview 
                      13.3.7.5. SWOT Analysis 
                      13.3.7.6. Strategic overview
            13.3.8. Mikrogen GmBH
                      13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.8.2. Business Overview
                      13.3.8.3. Product Portfolio 
                      13.3.8.4. Financial Overview 
                      13.3.8.5. SWOT Analysis 
                      13.3.8.6. Strategic overview
            13.3.9. MP Biomedicals, LLC.
                      13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.9.2. Business Overview
                      13.3.9.3. Product Portfolio 
                      13.3.9.4. Financial Overview 
                      13.3.9.5. SWOT Analysis 
                      13.3.9.6. Strategic overview
            13.3.10. Primerdesign Ltd.
                      13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.10.2. Business Overview
                      13.3.10.3. Product Portfolio 
                      13.3.10.4. Financial Overview 
                      13.3.10.5. SWOT Analysis 
                      13.3.10.6. Strategic overview    

List of Figures

Figure 1: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) and Forecast, 2016–2024
Figure 02: Global Market Value Share, by Test Type (2016)
Figure 03: Global Market Value Share, by End-user (2016)
Figure 04: Global Market Value Share, by Region (2016)
Figure 05: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 06: Global ELISA HEV IgM Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 07: Global ELISA HEV IgG Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 08: Global ELISA RT-PCR Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 09: Global Others Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 10: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 11: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
Figure 12: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 13: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 14: Global Research Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 15: Global Point of Care Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024
Figure 16: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
Figure 17: Global Hepatitis E Diagnostic Tests Market Revenue, US$ Mn, 2014–2024
Figure 18: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Region, 2015 and 2024
Figure 19: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Region, 2015
Figure 20: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024
Figure 21: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
Figure 22: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 23: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
Figure 24: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
Figure 25: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 26: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
Figure 27: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024
Figure 28: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
Figure 29: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 30: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
Figure 31: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
Figure 32: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 33: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
Figure 34: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024
Figure 35: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
Figure 36: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 37: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
Figure 38: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
Figure 39: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 40: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
Figure 41: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024
Figure 42: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
Figure 43: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 44: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
Figure 45: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
Figure 46: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 47: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
Figure 48: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024
Figure 49: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
Figure 50: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
Figure 51: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
Figure 52: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
Figure 53: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
Figure 54: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
Figure 55: Global Hepatitis E Diagnostic Tests Market Share Analysis, by Company (2015)

List of Tables

Table 01: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 02: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 04: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 05: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024
Table 06: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 07: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 08: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 09: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 10: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 11: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 12: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 13: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 14: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024
Table 15: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 16: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024
Table 17: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024
Table 18: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

Global Hepatitis E Diagnostic Tests Market: Overview 

Hepatitis E is a liver disease that is enterically transmitted and is caused by hepatitis E virus (HEV). It is one of the five known human hepatitis viruses (A, B, C, D, and E). Hepatitis E spreads through fecal-oral transmission due to fecal contamination of drinking water. The other routes of transmission of hepatitis E virus include transfusion of infected blood products, vertical transmission from a pregnant woman to her fetus, and ingestion of undercooked meat or meat products derived from infected animals. Infections with hepatitis E virus are commonly observed in regions with poor sanitation, including the Middle East, Asia, Central America, and Africa. The epidemiology and serology of HEV differs in developing and developed countries. It is considered to be rare in the U.S. and other developed regions. 

Cases of hepatitis E are not clearly distinguishable from other types of viral hepatitis. Hence, diagnosis can be confirmed by testing the presence of RNA and antibodies against HEV. Testing for the presence of IgM and IgG is considered to be indirect tests and testing for the presence of HEV RNA is considered to be direct test. Presence of IgM is the primary test to identify acute infections in patients, which is confirmed by testing for the presence of RNA. Presence of IgG antibodies indicates that the patient has been exposed previously to hepatitis E virus. 

This research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of hepatitis E diagnostic kits in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. 

Global Hepatitis E Diagnostic Tests Market: Scope of the Study 

The report provides estimated market size in terms of US$ Mn for each test type, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each test type was calculated by considering sero-prevalence rate of hepatitis E, average selling price of the kits, trends in industry, end user trend, and adoption rate across all the geographies. 

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on test type, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the hepatitis E diagnostic tests market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved from identification of the market need to their final reach to the end users. 

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the hepatitis E diagnostic tests market. 

Companies Mentioned in this report 

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the hepatitis E diagnostic tests market report are altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC., and Primerdesign Ltd., among others. 

The Hepatitis E Diagnostic Tests Market has been segmented as follows:

By Test Type

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Others 

By End User

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care 

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • A.E.
    • South Africa
    • Rest of Middle East and Africa


 
 
Back To Top